Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Large granular lymphocytic leukemia]

I Wyszecka-Polk1, W Prejzner

  • 1II Oddziału Chrób Wewnetrznych Szpitala Miejskiego w Wejherowie.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib.

Leukemia·2013
Same author

Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript.

Bone marrow transplantation·2006
Same author

Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia.

Clinical and laboratory haematology·2006
Same author

Imatinib therapy prior to myeloablative allogeneic stem cell transplantation.

Bone marrow transplantation·2005
Same author

Modification of the clonogenic capacity of bone marrow cells from normal individuals by the tyrosine kinase inhibitor STI571.

Clinical and laboratory haematology·2003
Same author

[Transplantation of hemopoietic stem cells in treatment of chronic myeloid leukemia].

Polskie Archiwum Medycyny Wewnetrznej·2002
Same journal

Cephalic tetanus progressing to generalized tetanus after facial trauma in an unvaccinated elderly patient: A case report.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
Same journal

Dynamics of ophthalmological symptoms due to vascular pathology of the central nervous system.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
Same journal

Mucous membrane pemphigoid with oral involvement: Two cases reports.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
Same journal

Patient autonomy and the right to refuse medical intervention: Medical and legal aspects.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
Same journal

A disciplinary alliance between obstetrics and infectious diseases: Building integrated perinatal safety systems.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
Same journal

It is everybody's right to be heard: Social exclusion and mental health.

Wiadomosci lekarskie (Warsaw, Poland : 1960)·2026
See all related articles

Large Granular Lymphocyte (LGL) Leukaemia is a rare disorder of LGL lymphocytes. This review covers LGL leukaemia classification, clinical features, and treatment options.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Context:

  • Large Granular Lymphocyte (LGL) Leukaemia is an uncommon lymphoproliferative disorder.
  • Characterized by an overgrowth of large granular lymphocytes.

Purpose:

  • To describe the classification of LGL Leukaemia.
  • To outline the clinical features associated with LGL Leukaemia.
  • To detail the treatment strategies for LGL Leukaemia.

Summary:

  • This review provides a comprehensive overview of Large Granular Lymphocyte (LGL) Leukaemia.
  • It details the current understanding of its classification and diagnostic criteria.
  • Key clinical manifestations and prognostic factors are discussed, alongside established and emerging treatment modalities.

Related Experiment Videos

Impact:

  • Enhances understanding of LGL Leukaemia for clinicians and researchers.
  • Facilitates accurate diagnosis and appropriate patient management.
  • Contributes to the development of improved therapeutic approaches for LGL Leukaemia.